We deliver fully integrated HEOR/RWD/RWE solutions with cutting-edge methodology, technology, and professional expertise. With our complete HEOR solutions, we effectively quantify and communicate the clinical and economic value of your products.
More than 100 team members (nearly the entire team) have advanced degrees from master’s to Ph.D.’s in a technical field.
We provide you with deep global insights to determine your products’ value to payers.
We understand how to navigate reimbursement requirements around the globe. We’ve completed more than 600 successful HTA filings in more than 50 countries.
We compile insightful dossiers, manuscripts, abstracts, poster reviews, and more.
We support your product development decisions and market access needs with our deep knowledge across a full range of modeling methods.
Our specialized in-house teams support smaller countries’ unique needs with consistent high-quality reports.
For valuable data about patient needs and market trends, we create comprehensive surveys and market research by accessing healthcare providers and patients.
If you need access to HEOR or RWE expertise, we partner with you to support short or long-term project needs.
To navigate the complexities of product positioning and to maximize your impact in the market, we offer in-depth market access solutions.
If you want to bring HEOR expertise in-house, we offer specialized team development services to mentor and train your employees.
Meet with a member of our team to find the right solutions for your life sciences company.
Talk to UsNews & Events
BioBridges is pleased to announce the appointment of Larry Blandford, PharmD, to its Board of Directors. He will play a key role in shaping BioBridges’ strategic vision and expanding the company’s market access capabilities. Bringing Deep Life Sciences Expertise Blandford brings nearly three decades of experience in healthcare services, with deep expertise in life sciences. […]
Industry Insights
Forward-looking organizations use real-world data long before a product reaches commercialization. If you’re a clinical operations leader, the pressure to design and execute efficient trials has never been higher. Timelines are tight, patient populations are hard to access, and regulatory expectations continue to evolve. In this environment, real-world evidence (RWE) is becoming increasingly critical—not just […]
